Navigation Links
Neurognostics pushes early prediction of brain disease

Milwaukee Score one for early prediction: Neurognostics, a firm in Milwaukee that develops devices for magnetic resonance imaging (MRI), has made strides since its founding two years ago toward the treatment of disorders before any physical signs develop.

"MRI is the most popular and useful mapping technique in the world ... in research," said Steve Rao, founder and chief science ......

Full article >>> no to study their drug Aricept, using MRI to analyze how effective it was in treating patients with multiple sclerosis. Tucker said Neurognostics is in the middle of negotiations with two other firms for similar projects.

"We assist the pharmaceutical company in making go or no go solutions, and we can do this by showing it's more sensitive then paper-pencil tests," Rao said.

......

Full article >>> mpany is trying to find new sites that have limited experience with functional MRI so they can learn how it operates in a neutral environment.

"We're hitting the pavement finding implementation sites," Tucker said.

Tucker said the company also plans to build off a Phase I Small Business Innovation Research grant the company received in October from the National Institutes of Heal......

Full article >>>
'"/>

Source:wistechnology.com By Les Chappell 03/16/05


Related biology technology :

1. Neurognostics to partner with Racine distributor
2. Neurognostics partners with Medical Numerics
3. Neurognostics recognized for MRI award
4. Neurognostics receives special FDA clearance for MindState fDAD
5. Neurognostics receives award for MRI innovation
6. Silva-Craig joins Neurognostics board
7. Wisconsin pushes for adoption of electronic health records
8. Biotech Alliance pushes ahead in SE Wisconsin with likely state funding
9. Rapid hit confirmation and early hERG liability testing using the IonWorks HT system
10. Venture Investors early-stage fund grows to $115 million
11. GE acquisition may boost "early" healthcare strategy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... U.S. Food and Drug Administration (FDA) has granted the company’s orphan drug designation ... company’s second orphan drug designation granted by the FDA. , Spinocerebellar ataxia ...
(Date:5/24/2016)... ... 2016 , ... Media Cybernetics, global image analysis leader, announces ... reflects a results-driven revitalization for a company with a renewed focus on innovation ... crisp, refreshed logo and a new web presence. , “I believe that the ...
(Date:5/23/2016)... , May 23, 2016 Oxitec ... 25 th at 10:15 a.m. ET before the United ... role genetically engineered mosquitos can play in controlling the spread ... of the Zika virus.      (Logo: http://photos.prnewswire.com/prnh/20150630/227348 ... male mosquito with a self-limiting gene. Trials in ...
(Date:5/22/2016)... , ... May 22, 2016 , ... Doctors in Rome ... combating the asbestos cancer, malignant mesothelioma. Surviving Mesothelioma has just posted an article on ... the University of Rome’s Department of Clinical Sciences and Translational Medicine evaluated more than ...
Breaking Biology Technology:
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
Breaking Biology News(10 mins):